Matches in Nanopublications for { ?s ?p "[Over-expression of ERBB2, a member of the family of transmembrane receptor tyrosine kinases, occurs in 15-30% of primary breast tumors and is associated with poor prognosis and chemoresistance to a variety of anticancer drugs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[Over-expression of ERBB2, a member of the family of transmembrane receptor tyrosine kinases, occurs in 15-30% of primary breast tumors and is associated with poor prognosis and chemoresistance to a variety of anticancer drugs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP514546.RAOBPGnT5cbZMTJ-uq_fjw2bXUKgm_B6-VbB4PmlCOSpE130_assertion description "[Over-expression of ERBB2, a member of the family of transmembrane receptor tyrosine kinases, occurs in 15-30% of primary breast tumors and is associated with poor prognosis and chemoresistance to a variety of anticancer drugs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP514546.RAOBPGnT5cbZMTJ-uq_fjw2bXUKgm_B6-VbB4PmlCOSpE130_provenance.
- assertion description "[Over-expression of ERBB2, a member of the family of transmembrane receptor tyrosine kinases, occurs in 15-30% of primary breast tumors and is associated with poor prognosis and chemoresistance to a variety of anticancer drugs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.